Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (621-630 of 818) with videos related to

Pageof 82
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1994
Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureusM D Sanford, A F Widmer, M J Bale, et al.
Journal of Chemotherapy (Florence, Italy)|April 1, 1994
Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacinN Yamane, R N Jones, R Frei, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1993
In vitro activity of three carbapenem antibiotics. Comparative studies with biapenem (L-627), imipenem, and meropenem against aerobic pathogens isolated worldwideD J Hoban, R N Jones, N Yamane, et al.
Diagnostic Microbiology and Infectious Disease|November 21, 1998
Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepimeR N Jones, D J Biedenbach, S A Marshall, et al.
Revista Da Associacao Medica Brasileira (1992)|July 1, 1996
[In vitro susceptibility testing of 446 clinical isolates of gram-positive bacteria to new quinolones, carbapenems and cephalosporins]R F Cereda, A C Pignatari, I L Leme, et al.
Diagnostic Microbiology and Infectious Disease|May 23, 1998
National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE ProgramM A Pfaller, R N Jones, S A Messer, et al.
Diagnostic Microbiology and Infectious Disease|May 8, 1998
Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study GroupR N Jones, M A Pfaller, G V Doern, et al.
Journal of Chemotherapy (Florence, Italy)|April 1, 1991
Use of antimicrobial susceptibility testing for epidemiology and the selection of oral, parenteral and topical regimens for control of CAPD-associated Staphylococcus aureus infectionA Pignatari, R N Jones, M R Barrett, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1992
Ofloxacin, a new broad-spectrum fluoroquinolone. Results from a Multicenter, National Comparative Activity Surveillance Study. The Ofloxacin Surveillance GroupR N Jones, L B Reller, L A Rosati, et al.
Journal of Clinical Microbiology|March 7, 2002
Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000M A Pfaller, D J Diekema, R N Jones, et al.
Pageof 82

Showing results (621-630 of 818) with videos related to

Sort By:
Pageof 82
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1994
Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureusM D Sanford, A F Widmer, M J Bale, et al.
Journal of Chemotherapy (Florence, Italy)|April 1, 1994
Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacinN Yamane, R N Jones, R Frei, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1993
In vitro activity of three carbapenem antibiotics. Comparative studies with biapenem (L-627), imipenem, and meropenem against aerobic pathogens isolated worldwideD J Hoban, R N Jones, N Yamane, et al.
Diagnostic Microbiology and Infectious Disease|November 21, 1998
Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepimeR N Jones, D J Biedenbach, S A Marshall, et al.
Revista Da Associacao Medica Brasileira (1992)|July 1, 1996
[In vitro susceptibility testing of 446 clinical isolates of gram-positive bacteria to new quinolones, carbapenems and cephalosporins]R F Cereda, A C Pignatari, I L Leme, et al.
Diagnostic Microbiology and Infectious Disease|May 23, 1998
National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE ProgramM A Pfaller, R N Jones, S A Messer, et al.
Diagnostic Microbiology and Infectious Disease|May 8, 1998
Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study GroupR N Jones, M A Pfaller, G V Doern, et al.
Journal of Chemotherapy (Florence, Italy)|April 1, 1991
Use of antimicrobial susceptibility testing for epidemiology and the selection of oral, parenteral and topical regimens for control of CAPD-associated Staphylococcus aureus infectionA Pignatari, R N Jones, M R Barrett, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1992
Ofloxacin, a new broad-spectrum fluoroquinolone. Results from a Multicenter, National Comparative Activity Surveillance Study. The Ofloxacin Surveillance GroupR N Jones, L B Reller, L A Rosati, et al.
Journal of Clinical Microbiology|March 7, 2002
Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000M A Pfaller, D J Diekema, R N Jones, et al.
Pageof 82